Antibody-Drug Conjugate Targets

E-ISSN： 1873-5576|9|8|982-1004

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.8, 2009-12, pp. : 982-1004

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Computational Approaches in Antibody-drug Conjugate Optimization for Targeted Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 18, Iss. 13, 2018-05 ,pp. : 1091-1109

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal antibody–drug conjugates

By Hamann Philip R

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1087-1103

Informa Healthcare

Access to resources Recommend Favorite

Brentuximab Vedotin (SGN-35), an antibody–drug conjugate for the treatment of CD30-positive malignancies

By Gualberto Antonio

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 205-216

Informa Healthcare

Access to resources Recommend Favorite

Investigational antibody-drug conjugates for hematological malignancies

By Polson Andrew G Ho William Y Ramakrishnan Vanitha

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 1, 2011-01 ,pp. : 75-85

Informa Healthcare

Access to resources Recommend Favorite

Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice

By Jumbe Nelson Xin Yan Leipold Douglas Crocker Lisa Dugger Debra Mai Elaine Sliwkowski Mark Fielder Paul Tibbitts Jay

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 37, Iss. 3, 2010-06 ,pp. : 221-242

Springer Publishing Company

Access to resources Recommend Favorite